Innoviva, Inc. INVA US Equity
Innoviva, Inc. (Nasdaq: INVA), an SEC filer in Pharmaceutical Preparations, closed at $20.97, +0.0%, on 2026-08-28, with a market cap of $1.5B as of 2026-08-27, a trailing P/E of 6.4, a return on equity of 29.1%, a net margin of 65.9% and 3-year sales growth of 7.5%. Institutional ownership, earnings history and filed financials are on the tabs below.